Flex Pharma (FLKS) Offers Regulatory, Clinical Update for FLX-787 for Treatment of Nocturnal Leg Cramp

Go back to Flex Pharma (FLKS) Offers Regulatory, Clinical Update for FLX-787 for Treatment of Nocturnal Leg Cramp

Flex Pharma Provides FLX-787 Nocturnal Leg Cramp Regulatory and Clinical Update

October 13, 2016 6:30 AM EDT

-- Efficacy Signals Seen in Subanalyses of Exploratory Human Studies of FLX-787 --

-- Parallel Design Phase 2 Trial Planned for First Half 2017 Based upon FDA Pre-IND Responses --

-- Conference Call and Webcast today at 8:45 a.m. ET --

BOSTON--(BUSINESS WIRE)-- Click to Tweet

... More

Flex Pharma Provides FLX-787 Nocturnal Leg Cramp Regulatory and Clinical Update

October 13, 2016 6:30 AM EDT

-- Efficacy Signals Seen in Subanalyses of Exploratory Human Studies of FLX-787 --

-- Parallel Design Phase 2 Trial Planned for First Half 2017 Based upon FDA Pre-IND Responses --

-- Conference Call and Webcast today at 8:45 a.m. ET --

BOSTON--(BUSINESS WIRE)-- Click to Tweet

... More